NAD+ Research Notes
Selected PubMed sources, evidence limits, and current BioPep USA catalog and documentation status for NAD+. Research use only.
Research-use-only scope: This article organizes published sources and BioPep USA records. It does not provide preparation, dosing, injection, human-use, animal-use, therapeutic, diagnostic, cosmetic, or clinical guidance.
NAD+ is a cellular cofactor rather than a peptide. The selected reviews cover NAD+ metabolism in ageing, cellular processes, and disease biology.
Questions covered by the selected literature
- How NAD+ metabolism is organized across cellular pathways
- Which changes are discussed during ageing
- Why pathway reviews do not establish an outcome for a catalog product
Evidence limits
These are broad metabolism reviews. They are used for terminology and pathway context, not as evidence for administration or a specific product outcome.
A paper should be read according to its own model, methods, controls, and endpoints. Cell, animal, analytical, review, and human records are not interchangeable.
Selected PubMed sources
- NAD(+) metabolism and its roles in cellular processes during ageing.. Nat Rev Mol Cell Biol. 2021 Feb. PMID: 33353981.
- NAD⁺ in aging, metabolism, and neurodegeneration.. Science. 2015 Dec 4. PMID: 26785480.
- Evolving concepts in NAD(+) metabolism.. Cell Metab. 2021 Jun 1. PMID: 33930322.
BioPep USA record
BioPep USA currently lists NAD+. Use the product page for current options and the documentation page for lot records.
Last reviewed: July 20, 2026.
